Join the Blujepa group to help and get support from people like you.
Blujepa News
Antibiotic Noninferior to Ceftriaxone + Azithromycin for Gonorrhea
MONDAY, April 21, 2025 – For uncomplicated urogenital gonorrhea, gepotidacin, which inhibits bacterial DNA replication, is noninferior to ceftriaxone plus azithromycin, according to a study...
New Antibiotic Blujepa May Be Effective in Treating Gonorrhea
TUESDAY, April 15, 2025 — A newly approved antibiotic to treat urinary tract infections may also help fight drug-resistant gonorrhea, a new study shows. The medication, called gepotidacin, sold under ...
FDA Approves Blujepa for Uncomplicated Urinary Tract Infections
TUESDAY, March 25, 2025 – The U.S. Food and Drug Administration has approved Blujepa (gepotidacin) for the treatment of uncomplicated urinary tract infections (uUTIs) in adult women (weighing 40 kg...
FDA Approves Blujepa (gepotidacin) for the Treatment of Uncomplicated Urinary Tract Infections
London, UK – 25 March 2025 – GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved Blujepa (gepotidacin) for the treatment of female adults (≥40 kg) a...